Oxfam accuses Pfizer of “moral bankruptcy”BMJ 2001; 323 doi: https://doi.org/10.1136/bmj.323.7306.186/b (Published 28 July 2001) Cite this as: BMJ 2001;323:186
- Rory Watson
Pfizer, the world's largest pharmaceutical company, is being accused of moral bankruptcy by pricing lifesaving drugs beyond the reach of millions of people in developing countries.
The charge comes from the United Kingdom based charity, Oxfam, which is campaigning to end the company's single pricing policy and is pressing for more flexible use of patent rules.
In a new report released simultaneously in eight countries, Oxfam has claimed that the company has aggressively …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial